Sihuan Pharmaceuticals Hong Kong IPO Draws Major Cornerstone Investors
SINGAPORE - An initial public offering in Hong Kong by Sihuan Pharmaceuticals Group has attracted major cornerstone investors, including billionaire investor George Soros, China Life Insurance (Overseas), and the Yun Feng Fund for a combined $190 million